Population
Heart failure
Design
Preclinical
Authors
Loading...
Receptor-specific TNF modulation merits preclinical testing in HF; leaves open translation to human outcomes.
TNFR1 and TNFR2 have opposing effects on cardiac remodeling in heart failure, highlighting the need for receptor-specific approaches in anti-TNF therapies.
Hamid et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: